title: Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis.
authors: Johanna M
authors: JM
authors: Kwakkel-van Erp
authors: Inge M
authors: IM
authors: Haeck
authors: Annelieke W M
authors: AW
authors: Paantjens
authors: Ed A
authors: EA
authors: van de Graaf
authors: Walter G J
authors: WG
authors: van Ginkel
authors: Mirjam J
authors: MJ
authors: Knol
authors: Marjolein S
authors: MS
authors: de Bruin-Weller
authors: Jan-Willem J
authors: JW
authors: Lammers
authors: Edward F
authors: EF
authors: Knol
authors: Carla
authors: C
authors: Bruijnzeel-Koomen
authors: Henny G
authors: HG
authors: Otten
mesh_terms: D015415:Biomarkers / Q000097:blood; D054414:Chemokine CCL17 / Q000032:analysis / Q000097:blood*; D016572:Cyclosporine / Q000627:therapeutic use*; D003876:Dermatitis, Atopic / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D017730:Ki-1 Antigen / Q000032:analysis / Q000097:blood*; D008297:Male; D009173:Mycophenolic Acid / Q000627:therapeutic use*; D015588:Observer Variation; D010865:Pilot Projects; D011379:Prognosis; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D016037:Single-Blind Method; D013608:Tablets, Enteric-Coated; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D054414:Chemokine CCL17; D017730:Ki-1 Antigen; D013608:Tablets, Enteric-Coated; D016572:Cyclosporine; D009173:Mycophenolic Acid